ReNerve appoints distribution partner for Malaysian Market
Open PDF
| Stock | RNV.ASX (RNV.ASX) |
|---|---|
| Release Time | 5 Jun 2026, 9:15 a.m. |
| Price Sensitive | Yes |
This feature provides summaries of price-sensitive announcements for companies followed by users on InvestorPA.
The summaries are generated by large language models so please interpret with care.
ReNerve Partners with UG Medical for Malaysian Market
Key Points
- Distribution agreement with UG Medical for Malaysian market
- UG Medical has extensive network across Malaysia
- ReNerve's NervAlign received regulatory clearance in Malaysia
Full Summary
ReNerve Limited, an Australian biotechnology company, has announced a partnership with UG Medical, a leading medical device distributor in Malaysia, to commercialize its NervAlign products. This partnership aims to expand ReNerve's presence in the Malaysian market, which has a population of approximately 33 million and a rapidly growing healthcare sector. UG Medical will handle importation, regulatory management, and warehousing, while collaborating with ReNerve on marketing, sales, and distribution. ReNerve's NervAlign Nerve Cuff has already received regulatory clearance in Malaysia, and the company plans to launch its nerve conduit product later this year. The agreement is open-ended and on customary commercial terms.
Sign in to get more information about the company, including guidance changes and other insights.
Sign In